Yingliang Wang
About
In The Last Decade
Yingliang Wang
51 papers receiving 588 citations
Peers
Comparison fields: 5 of 78
- Hepatology 247
- Epidemiology 193
- Molecular Biology 150
- Surgery 115
- Cancer Research 104
Countries citing papers authored by Yingliang Wang
This map shows the geographic impact of Yingliang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingliang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingliang Wang more than expected).
Fields of papers citing papers by Yingliang Wang
This network shows the impact of papers produced by Yingliang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingliang Wang. The network helps show where Yingliang Wang may publish in the future.
Co-authorship network of co-authors of Yingliang Wang
This figure shows the co-authorship network connecting the top 25 collaborators of Yingliang Wang. A scholar is included among the top collaborators of Yingliang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingliang Wang. Yingliang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 2 | |
| 4 | 19 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 1 | |
| 8 | 3 | |
| 9 | 45 | |
| 10 | 4 | |
| 11 | 4 | |
| 12 | 8 | |
| 13 | 17 | |
| 14 | 6 | |
| 15 | 5 | |
| 16 | 12 | |
| 17 | 5 | |
| 18 | 11 | |
| 19 | 48 | |
| 20 | Honokiol possesses potential anti-inflammatory effects on rheumatoid arthritis and GM-CSF can be a target for its treatment. | 20 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.